Enhanced genetic rescue of negative-strand RNA viruses

Use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors

Gerald R. Kovacs, Christopher L. Parks, Nikos Vasilakis, Stephen A. Udem

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A modified cDNA rescue system that improves recovery of recombinant nonsegmented, negative-strand RNA viruses from cloned DNAs is described. Rescue systems based on vaccinia virus-T7 RNA polymerase vectors have been used to derive many negative-strand viruses; however, some strains can be recalcitrant to rescue possibly because of the simultaneous replication of the vaccinia virus-T7 vector. Our goal was to engineer a system where replication of the vaccinia virus-T7 vector could be blocked, yet allow for sufficient T7 RNA polymerase expression to enable genetic rescue. To that end, a recombinant modified vaccinia virus Ankara (MVA) was engineered that contained the bacteriophage T7 gene-1 under the control of a strong early promoter that would enable T7 RNA polymerase expression in the absence of MVA DNA replication. The new T7 helper, MVAGKT7, was then utilized successfully for the genetic rescue of a measles virus minigenome and full-length cDNAs, in the presence of DNA synthesis inhibitors. In addition to blocking completely MVAGKT7 replication, AraC treatment was found to enhance minigenome-encoded gene expression and the efficiency of measles virus rescue.

Original languageEnglish (US)
Pages (from-to)29-36
Number of pages8
JournalJournal of Virological Methods
Volume111
Issue number1
DOIs
StatePublished - Jul 1 2003

Fingerprint

Vaccinia virus
RNA Viruses
DNA Replication
Measles virus
Complementary DNA
Nucleic Acid Synthesis Inhibitors
Bacteriophage T7
bacteriophage T7 RNA polymerase
Viruses
Gene Expression
DNA
Genes

Keywords

  • Measles virus
  • T7 RNA polymerase
  • Vaccinia virus

ASJC Scopus subject areas

  • Virology

Cite this

Enhanced genetic rescue of negative-strand RNA viruses : Use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors. / Kovacs, Gerald R.; Parks, Christopher L.; Vasilakis, Nikos; Udem, Stephen A.

In: Journal of Virological Methods, Vol. 111, No. 1, 01.07.2003, p. 29-36.

Research output: Contribution to journalArticle

@article{60952d322b3040f780282b732f896253,
title = "Enhanced genetic rescue of negative-strand RNA viruses: Use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors",
abstract = "A modified cDNA rescue system that improves recovery of recombinant nonsegmented, negative-strand RNA viruses from cloned DNAs is described. Rescue systems based on vaccinia virus-T7 RNA polymerase vectors have been used to derive many negative-strand viruses; however, some strains can be recalcitrant to rescue possibly because of the simultaneous replication of the vaccinia virus-T7 vector. Our goal was to engineer a system where replication of the vaccinia virus-T7 vector could be blocked, yet allow for sufficient T7 RNA polymerase expression to enable genetic rescue. To that end, a recombinant modified vaccinia virus Ankara (MVA) was engineered that contained the bacteriophage T7 gene-1 under the control of a strong early promoter that would enable T7 RNA polymerase expression in the absence of MVA DNA replication. The new T7 helper, MVAGKT7, was then utilized successfully for the genetic rescue of a measles virus minigenome and full-length cDNAs, in the presence of DNA synthesis inhibitors. In addition to blocking completely MVAGKT7 replication, AraC treatment was found to enhance minigenome-encoded gene expression and the efficiency of measles virus rescue.",
keywords = "Measles virus, T7 RNA polymerase, Vaccinia virus",
author = "Kovacs, {Gerald R.} and Parks, {Christopher L.} and Nikos Vasilakis and Udem, {Stephen A.}",
year = "2003",
month = "7",
day = "1",
doi = "10.1016/S0166-0934(03)00132-0",
language = "English (US)",
volume = "111",
pages = "29--36",
journal = "Journal of Virological Methods",
issn = "0166-0934",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Enhanced genetic rescue of negative-strand RNA viruses

T2 - Use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors

AU - Kovacs, Gerald R.

AU - Parks, Christopher L.

AU - Vasilakis, Nikos

AU - Udem, Stephen A.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - A modified cDNA rescue system that improves recovery of recombinant nonsegmented, negative-strand RNA viruses from cloned DNAs is described. Rescue systems based on vaccinia virus-T7 RNA polymerase vectors have been used to derive many negative-strand viruses; however, some strains can be recalcitrant to rescue possibly because of the simultaneous replication of the vaccinia virus-T7 vector. Our goal was to engineer a system where replication of the vaccinia virus-T7 vector could be blocked, yet allow for sufficient T7 RNA polymerase expression to enable genetic rescue. To that end, a recombinant modified vaccinia virus Ankara (MVA) was engineered that contained the bacteriophage T7 gene-1 under the control of a strong early promoter that would enable T7 RNA polymerase expression in the absence of MVA DNA replication. The new T7 helper, MVAGKT7, was then utilized successfully for the genetic rescue of a measles virus minigenome and full-length cDNAs, in the presence of DNA synthesis inhibitors. In addition to blocking completely MVAGKT7 replication, AraC treatment was found to enhance minigenome-encoded gene expression and the efficiency of measles virus rescue.

AB - A modified cDNA rescue system that improves recovery of recombinant nonsegmented, negative-strand RNA viruses from cloned DNAs is described. Rescue systems based on vaccinia virus-T7 RNA polymerase vectors have been used to derive many negative-strand viruses; however, some strains can be recalcitrant to rescue possibly because of the simultaneous replication of the vaccinia virus-T7 vector. Our goal was to engineer a system where replication of the vaccinia virus-T7 vector could be blocked, yet allow for sufficient T7 RNA polymerase expression to enable genetic rescue. To that end, a recombinant modified vaccinia virus Ankara (MVA) was engineered that contained the bacteriophage T7 gene-1 under the control of a strong early promoter that would enable T7 RNA polymerase expression in the absence of MVA DNA replication. The new T7 helper, MVAGKT7, was then utilized successfully for the genetic rescue of a measles virus minigenome and full-length cDNAs, in the presence of DNA synthesis inhibitors. In addition to blocking completely MVAGKT7 replication, AraC treatment was found to enhance minigenome-encoded gene expression and the efficiency of measles virus rescue.

KW - Measles virus

KW - T7 RNA polymerase

KW - Vaccinia virus

UR - http://www.scopus.com/inward/record.url?scp=0037735244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037735244&partnerID=8YFLogxK

U2 - 10.1016/S0166-0934(03)00132-0

DO - 10.1016/S0166-0934(03)00132-0

M3 - Article

VL - 111

SP - 29

EP - 36

JO - Journal of Virological Methods

JF - Journal of Virological Methods

SN - 0166-0934

IS - 1

ER -